On track to submit GraftAssureDx™ for FDA review by year-endOn track for commitment to have 20 transplant centers globally ...

Wasatch reports WGROX’s worst quarter in 20+ years, but reaffirms conviction in high-quality growth. See how the fund is ...

Art and science building intelligence at the point of conversation enhances clinical decision-making and patient care across health systems.

The Russell 2500 Index was up 9.00%. The Wasatch Long/Short Alpha Fund—Investor Class did not keep pace and finished the ...

Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year periodThird Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year periodAdjusted ...

This week, the government shutdown entered its fifth week and, on Nov. 4, 2025, became the longest in history, beating a 34-day-plus record set ...

Background The epidemiology of sudden cardiac arrest (SCA) in the Mediterranean area remains unclear. The aim of this study ...

Over 25 years leading global quality and regulatory organizations, Ive learned that the most difficult challenges arent ...

In the dynamic environment of biotechnology trials, the significance of Clinical Data Management systems (CDMs) cannot be overstated. As we navigate the complexities of these trials and the pivotal ...

The revenue of Lundbeck's strategic brands increased by +20% CER (+18% DKK), reaching DKK 14,260 million, representing 77% of total revenue. Rexulti ®: DKK 4,695 million (+26% CE ...

Allied Market Research published a report, titled, "Pharmacovigilance Market By Type (Services and Software), Process Flow ...